##fileformat=VCFv4.0
##source=ClinVar
##reference=GRCh38
##INFO=<ID=HGVS,Number=.,Type=String,Description="">
##INFO=<ID=Submitter,Number=.,Type=String,Description="">
##INFO=<ID=ClinicalSignificance,Number=.,Type=String,Description="">
##INFO=<ID=DateLastUpdated,Number=.,Type=String,Description="">
##INFO=<ID=SCV,Number=.,Type=String,Description="">
##INFO=<ID=ID,Number=.,Type=String,Description="">
##INFO=<ID=Origin,Number=.,Type=String,Description="">
##INFO=<ID=Method,Number=.,Type=String,Description="">
##INFO=<ID=Genomic_Coordinate,Number=.,Type=String,Description="">
##INFO=<ID=Symbol,Number=.,Type=String,Description="">
##INFO=<ID=Protein,Number=.,Type=String,Description="">
##INFO=<ID=Description,Number=.,Type=String,Description="">
#CHROM  POS ID  REF ALT QUAL    FILTER  INFO
13  32331002    .   CACAAA  AAACAAT .   .   HGVS=NM_000059.3.c.765_770delCACAAAinsAAACAAT;Submitter=Consortium_of_Investigators_of_Modifiers_of_BRCA1/2_(CIMBA),_c/o_University_of_Cambridge;ClinicalSignificance=Pathogenic;DateLastUpdated=2015-10-02;SCV=SCV000327703;ID=626811;Origin=germline;Method=clinical_testing;Genomic_Coordinate=chr13.32331002.CACAAA>AAACAAT;Symbol=BRCA2;Protein=NP_000050.2.p.Asn255Lysfs;Description=not_provided;BX_ID=1
13  32331004    .   CA  -   .   .   HGVS=NM_000059.3.c.767_768delCA;Submitter=Invitae_;ClinicalSignificance=not_provided;DateLastUpdated=2013-02-01;SCV=SCV000073295;ID=121225;Origin=germline;Method=literature_only;Genomic_Coordinate=chr13.32331004.CA>-;Symbol=BRCA2;Protein=NP_000050.2.p.Thr256Lysfs;Description=not_provided;BX_ID=2
13  32331004    .   C   -   .   .   HGVS=NM_000059.3.c.767delC;Submitter=Invitae_;ClinicalSignificance=not_provided;DateLastUpdated=2013-02-01;SCV=SCV000073296;ID=121226;Origin=germline;Method=literature_only;Genomic_Coordinate=chr13.32331004.C>-;Symbol=BRCA2;Protein=NP_000050.2.p.Thr256Lysfs;Description=not_provided;BX_ID=3
13  32331004    .   CA  -   .   .   HGVS=NM_000059.3.c.767_768delCA;Submitter=Consortium_of_Investigators_of_Modifiers_of_BRCA1/2_(CIMBA),_c/o_University_of_Cambridge;ClinicalSignificance=Pathogenic;DateLastUpdated=2015-10-02;SCV=SCV000327708;ID=626816;Origin=germline;Method=clinical_testing;Genomic_Coordinate=chr13.32331004.CA>-;Symbol=BRCA2;Protein=NP_000050.2.p.Thr256Lysfs;Description=not_provided;BX_ID=4
13  32331004    .   CA  -   .   .   HGVS=NM_000059.3.c.767_768delCA;Submitter=Breast_Cancer_Information_Core_(BIC)_(BRCA2);ClinicalSignificance=Pathogenic;DateLastUpdated=1998-11-30;SCV=SCV000147706;ID=264604;Origin=germline;Method=clinical_testing;Genomic_Coordinate=chr13.32331004.CA>-;Symbol=BRCA2;Protein=NP_000050.2.p.Thr256Lysfs;Description=None;BX_ID=5
13  32331004    .   CA  -   .   .   HGVS=NM_000059.3.c.767_768delCA;Submitter=Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA);ClinicalSignificance=Pathogenic;DateLastUpdated=2016-09-08;SCV=SCV000300358;ID=581415;Origin=germline;Method=curation;Genomic_Coordinate=chr13.32331004.CA>-;Symbol=BRCA2;Protein=NP_000050.2.p.Thr256Lysfs;Description=not_provided;BX_ID=6
13  32331004    .   C   -   .   .   HGVS=NM_000059.3.c.767delC;Submitter=Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA);ClinicalSignificance=Pathogenic;DateLastUpdated=2016-04-22;SCV=SCV000282447;ID=537178;Origin=germline;Method=curation;Genomic_Coordinate=chr13.32331004.C>-;Symbol=BRCA2;Protein=NP_000050.2.p.Thr256Lysfs;Description=not_provided;BX_ID=7
13  32331004    .   C   -   .   .   HGVS=NM_000059.3.c.767delC;Submitter=Consortium_of_Investigators_of_Modifiers_of_BRCA1/2_(CIMBA),_c/o_University_of_Cambridge;ClinicalSignificance=Pathogenic;DateLastUpdated=2015-10-02;SCV=SCV000327712;ID=626820;Origin=germline;Method=clinical_testing;Genomic_Coordinate=chr13.32331004.C>-;Symbol=BRCA2;Protein=NP_000050.2.p.Thr256Lysfs;Description=not_provided;BX_ID=8
13  32331004    .   CA  -   .   .   HGVS=NM_000059.3.c.767_768delCA;Submitter=Ambry_Genetics;ClinicalSignificance=Pathogenic;DateLastUpdated=2015-02-26;SCV=SCV000186902;ID=305417;Origin=germline;Method=clinical_testing;Genomic_Coordinate=chr13.32331004.CA>-;Symbol=BRCA2;Protein=NP_000050.2.p.Thr256Lysfs;Description=None;BX_ID=9
13  32331004    .   C   T   .   .   HGVS=NM_000059.3.c.767C>T;Submitter=GeneDx;ClinicalSignificance=Uncertain_significance;DateLastUpdated=2016-06-24;SCV=SCV000568542;ID=1103649;Origin=germline;Method=clinical_testing;Genomic_Coordinate=chr13.32331004.C>T;Symbol=BRCA2;Protein=NP_000050.2.p.Thr256Ile;Description=not_provided;BX_ID=10
13  32331007    .   A   C   .   .   HGVS=NM_000059.3.c.770A>C;Submitter=Ambry_Genetics;ClinicalSignificance=Uncertain_significance;DateLastUpdated=2014-07-07;SCV=SCV000186277;ID=304792;Origin=germline;Method=clinical_testing;Genomic_Coordinate=chr13.32331007.A>C;Symbol=BRCA2;Protein=NP_000050.2.p.Asn257Thr;Description=None;BX_ID=11
13  32331008    .   TCAAA   -   .   .   HGVS=NM_000059.3.c.771_775delTCAAA;Submitter=Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano,;ClinicalSignificance=Pathogenic;DateLastUpdated=2015-02-02;SCV=SCV000296746;ID=574317;Origin=germline;Method=clinical_testing;Genomic_Coordinate=chr13.32331008.TCAAA>-;Symbol=BRCA2;Protein=NP_000050.2.p.Asn257Lysfs;Description=not_provided;BX_ID=12
13  32331008    .   TCAAA   -   .   .   HGVS=NM_000059.3.c.771_775delTCAAA;Submitter=Breast_Cancer_Information_Core_(BIC)_(BRCA2);ClinicalSignificance=Pathogenic;DateLastUpdated=2002-05-29;SCV=SCV000147710;ID=264608;Origin=germline;Method=clinical_testing;Genomic_Coordinate=chr13.32331008.TCAAA>-;Symbol=BRCA2;Protein=NP_000050.2.p.Asn257Lysfs;Description=None;BX_ID=13
13  32331008    .   TCAAA   -   .   .   HGVS=NM_000059.3.c.771_775delTCAAA;Submitter=Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA);ClinicalSignificance=Pathogenic;DateLastUpdated=2016-09-08;SCV=SCV000300360;ID=581417;Origin=germline;Method=curation;Genomic_Coordinate=chr13.32331008.TCAAA>-;Symbol=BRCA2;Protein=NP_000050.2.p.Asn257Lysfs;Description=not_provided;BX_ID=14
13  32331008    .   TCAAA   -   .   .   HGVS=NM_000059.3.c.771_775delTCAAA;Submitter=OMIM;ClinicalSignificance=Pathogenic;DateLastUpdated=2000-05-01;SCV=SCV000030134;ID=30134;Origin=germline;Method=literature_only;Genomic_Coordinate=chr13.32331008.TCAAA>-;Symbol=BRCA2;Protein=NP_000050.2.p.Asn257Lysfs;Description=Thorlacius_et_al._(1997)_found_a_5-bp_deletion_in_exon_9_starting_at_nucleotide_999_(999del5)_and_leading_to_early_protein_termination,_in_16_of_21_Icelandic_breast_cancer_families_(BROVCA2._612555),_indicating_a_founder_effect._They_detected_a_999del5_germline_mutation_in_0.6%_of_the_Icelandic_population,_in_7.7%_of_female_breast_cancer_patients,_and_in_40%_of_males_with_breast_cancer._The_mutation_was_strongly_associated_with_onset_of_female_breast_cancer_at_age_less_than_50_years._A_number_of_cancers_other_than_breast_cancer_were_found_to_be_increased_in_relatives_of_mutation_carriers,_including_those_with_prostate_and_pancreatic_cancer._Comparison_of_the_age_at_onset_for_mother/daughter_pairs_with_the_999del5_mutation_in_breast_cancer_indicated_that_age_at_onset_was_decreasing_in_the_younger_generation._Increasing_breast_cancer_incidence_and_lower_age_at_onset_suggested_a_possible_contributing_environmental_factor.;BX_ID=15
17  43127865    .   A   G   .   .   HGVS=NM_007294.3.c.-2614T>C;Submitter=Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA);ClinicalSignificance=Benign;DateLastUpdated=2015-01-12;SCV=SCV000244907;ID=456402;Origin=germline;Method=curation;Genomic_Coordinate=chr17.43127865.A>G;Symbol=BRCA1;Protein=None;Description=not_provided;BX_ID=16
17  43127867    .   AC  -   .   .   HGVS=NM_007294.3.c.-2617_-2616del;Submitter=Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA);ClinicalSignificance=Benign;DateLastUpdated=2015-01-12;SCV=SCV000244908;ID=456403;Origin=germline;Method=curation;Genomic_Coordinate=chr17.43127867.AC>-;Symbol=BRCA1;Protein=None;Description=not_provided;BX_ID=17
